test-4
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type...
DLBCL Congress Videos Sharing
醫學新知
SMArt Network recordings
ARVO 2022 KESTREL and KITE studies 100 week result
ARVO 2022 KESTREL and KITE studies 100 week result
...
Brolucizumab for treatment of diabetic macular edema (DME): 100-week results from the KESTREL and KITE studies
Brolucizumab for treatment of diabetic macular edema (DME): 100-week results from the KESTREL and KITE studies (EURETINA)
...
日本發表之18個月Brolucizumab nAMD switch study
日本發表之 18 個月 Brolucizumab nAMD switch study ( 包含 Type1 CNV 及 PCV data)
Switching to...
REALIZE Brolucizumab nAMD switch study:
德國發表之 REALIZE Brolucizumab nAMD switch stu dy:
Disease area landing page
醫藥學術顧問諮詢
若您需要任何醫藥學術諮詢,請填寫諮詢需求表單並送出,我們會儘速和您聯絡。 若有文獻查詢問題, 請至技術支援(Help)頁面詢問
×